Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000919574-21-005976
Filing Date
2021-09-24
Accepted
2021-09-24 16:40:15
Documents
8

Document Format Files

Seq Description Document Type Size
1 d8965200_13d-a.htm SC 13D/A 107667
2 GRAPHIC image_001.jpg GRAPHIC 115764
3 GRAPHIC image_003.jpg GRAPHIC 103081
4 GRAPHIC image_004.jpg GRAPHIC 136981
5 GRAPHIC image_005.jpg GRAPHIC 127203
6 GRAPHIC image_006.jpg GRAPHIC 91051
7 GRAPHIC image_007.jpg GRAPHIC 49915
8 GRAPHIC image_008.jpg GRAPHIC 63560
  Complete submission text file 0000919574-21-005976.txt   1057396
Mailing Address BROADWOOD CAPITAL INC. 142 WEST 57TH STREET, 11TH FLOOR NEW YORK NY 10019
Business Address BROADWOOD CAPITAL INC. 142 WEST 57TH STREET, 11TH FLOOR NEW YORK NY 10019 212-508-5735
BROADWOOD PARTNERS, L.P. (Filed by) CIK: 0001278386 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 15 CUSHING IRVINE CA 92618
Business Address 15 CUSHING IRVINE CA 92618 949-409-7600
Oncocyte Corp (Subject) CIK: 0001642380 (see all company filings)

EIN.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-89221 | Film No.: 211277865
SIC: 2835 In Vitro & In Vivo Diagnostic Substances